Correlates of Amount Spent on Marijuana Buds During a Discrete Purchase at Medical Marijuana Dispensaries: Results from a Pilot Study

Journal of Psychoactive Drugs

Volumn 48, Issue 1, 2016, Pages 50-55

  Kepple, Nancy Jo ^a   Mulholland, Elycia ^b   Freisthler, Bridget ^b   Schaper, Elizabeth ^b  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Discrete purchase; dispensary; medical conditions; medical marijuana

Indexed keywords

CANNABIS; MEDICAL CANNABIS;

ADULT; AMBULATORY CARE; ARTICLE; CHRONIC PAIN; DEMOGRAPHY; FEMALE; HEALTH BEHAVIOR; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PILOT STUDY; REGRESSION ANALYSIS; STATISTICS; ADOLESCENT; AGED; CALIFORNIA; CONSUMER ATTITUDE; ECONOMICS; PHARMACY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALIFORNIA; CONSUMER BEHAVIOR; FEMALE; HUMANS; MALE; MEDICAL MARIJUANA; MIDDLE AGED; PHARMACIES; PILOT PROJECTS; YOUNG ADULT;

EID: 84961140971     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2015.1116719     Document Type: Article

References (26)

1. A.J.Budney,, and J.R.Hughes. 2006. The cannabis withdrawal syndrome. Current Opinion in Psychiatry 19 (3):233–38. doi:10.1097/01.yco.0000218592.00689.e5.
2. California Compassionate Use Act. 1996. Cal. Health & Saf. Code § 11362.5. Retrieved December 1, 2014, from http://www.cdph.ca.gov/programs/MMP/Pages/CompassionateUseact.aspx
3. J.P.Caulkins,, and R.L.Pacula 2005. Marijuana markets: Inferences from reports by the household population. Paper 20. Heinz Research. Available at: http://repository.cmu.edu/heinzworks/20
4. J.P.Caulkins,, and R.L.Pacula. 2006. Marijuana markets: Inferences from reports by the household population. Journal of Drug Issues 36 (1):173–200. doi:10.1177/002204260603600108.
5. C.E.Grella,, and L.Rodriguez. 2014. Differences between younger and older medical marijuana users from a cluster-based sample of dispensaries in Los Angeles. Drug and Alcohol Dependence 140:e75–e76. doi:10.1016/j.drugalcdep.2014.02.225.
6. P.J.Gruenewald, 2007. The spatial ecology of alcohol problems: Niche theory and assortative drinking. Addiction 102 (6):870–78. doi:10.1111/add.2007.102.issue-6.
7. M.Haney,, A.S.Ward, S.D.Comer, R.W.Foltin, and M.W.Fischman. 1999. Abstinence symptoms following smoked marijuana in humans. Psychopharmacology 141 (4):395–404. doi:10.1007/s002130050849.
8. S.Harder,, and S.Rietbrock. 1997. Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana. International Journal of Clinical Pharmacology and Therapeutics 35:155–59. PMID: 9112136
9. P.Lucas,, A.Reiman, M.Earleywine, S.K.McGowan, M.Oleson, M.P.Coward, and B.Thomas. 2013. Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients. Addiction Research & Theory 21:435–42. doi:10.3109/16066359.2012.733465.
10. E.Martín‐Sánchez,, T.A.Furukawa, J.Taylor, and J.L.R.Martin. 2009. Systematic review and meta‐analysis of cannabis treatment for chronic pain. Pain Medicine 10 (8):1353–68. doi:10.1111/j.1526-4637.2009.00703.x.
11. B.A.Miller,, C.D.Furr-Holden, R.B.Voas, and K.Bright. 2005. Emerging adults’ substance use and risky behaviors in club settings. Journal of Drug Issues 35 (2):357–78. doi:10.1177/002204260503500207.
12. D.Newman,, and I.Newman. 2012. Multilevel modeling: Clarifying issues of concern. Multiple Linear Regression Viewpoints 38 (1):26–33.
13. H.Nunberg,, B.Kilmer, R.L.Pacula, and J.R.Burgdorf. 2011. An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis 4 (1). Online. doi:10.2202/1941-2851.1017.
14. T.J.O’Connell,, and C.B.Bou-Matar. 2007. Long-term marijuana users seeking medical cannabis in California (2001–2007): Demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduction Journal 4 (16). Online. doi:10.1186/1477-7517-4-16.
15. R.L.Pacula,, B.Kilmer, M.Grossman, and F.J.Chaloupka. 2010. Risks and prices: The role of user sanctions in marijuana markets. The BE Journal of Economic Analysis & Policy 10 (1). Article 11. Online. doi:10.2202/1935-1682.1992.
16. R.L.Pacula,, B.Kilmer, A.C.Wagenaar, F.J.Chaloupka, and J.P.Caulkins. 2014. Developing public health regulations for marijuana: Lessons from alcohol and tobacco. American Journal of Public Health 104 (6):1021–28. doi:10.2105/AJPH.2013.301766.
17. R.L.Pacula,, D.Powell, P.Heaton, and E.L.Sevigny. 2015. Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details. Journal of Policy Analysis and Management 34 (1):7–31. doi:10.1002/pam.2015.34.issue-1.
18. R.L.Pacula,, and E.L.Sevigny. 2014. Marijuana liberalization policies: Why we can’t learn much from policy still in motion. Journal of Policy Analysis and Management 33 (1):212–21. doi:10.1002/pam.21726.
19. S.W.Raudenbush,, and A.S.Bryk. 2002. Hierarchical linear models: Applications and data analysis methods, vol. 1. Thousand Oaks, CA: Sage.
20. A.Reiman, 2007. Medical cannabis patients: Patient profiles and health care utilization patterns. Journal of Evidence-based Complementary & Alternative Medicine 12 (1):31–50. doi:10.1177/1533210107301834.
21. C.Reinarman,, H.Nunberg, F.Lanthier, and T.Heddleston. 2011. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. Journal of Psychoactive Drugs 43 (2):128–35. doi:10.1080/02791072.2011.587700.
22. S.Ryan‐Ibarra,, M.Induni, and D.Ewing. 2014. Prevalence of medical marijuana use in California, 2012. Drug and Alcohol Review 34 (2):141–46. doi:10.1111/dar.12207.
23. S.Salomonsen-Sautel,, J.T.Sakai, C.Thurstone, R.Corley, and C.Hopfer. 2012. Medical marijuana use among adolescents in substance abuse treatment. Journal of the American Academy of Child & Adolescent Psychiatry 51 (7):694–702. doi:10.1016/j.jaac.2012.04.004.
24. E.L.Sevigny,, R.L.Pacula, and P.Heaton. 2014. The effects of medical marijuana laws on potency. International Journal of Drug Policy 25:308–19. doi:10.1016/j.drugpo.2014.01.003.
25. L.Staner, 2003. Sleep and anxiety disorders. Dialogues in Clinical Neuroscience 5 (3):249–58.
26. A.C.Wagenaar,, M.J.Salois, and K.A.Komro. 2009. Effects of beverage alcohol price and tax levels on drinking: A meta‐analysis of 1003 estimates from 112 studies. Addiction 104 (2):179–90. doi:10.1111/add.2009.104.issue-2.